Flammer Martina M.D.'s Form 4 filing
INSMED Inc (INSM) · filed May 19, 2025
- Accession no.
- 0001628280-25-026581
- Filed
- May 19, 2025
- Trade date
- May 15-16, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $771.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Flammer Martina M.D.CIK 0001796960 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 15, 2025 | Common Stock | AGrant or awardAcquired | +6,508 | $0.00F2 | $0 | 96,521 | Direct | |
| May 15, 2025 | Common Stock | SSaleDisposed | −9,925 | $65.47F4 | −$649,789.75 | 86,596 | Direct | |
| May 16, 2025 | Common Stock | SSaleDisposed | −1,799 | $67.53 | −$121,486.47 | 84,797 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 15, 2025 | Common Stock | AGrant or awardAcquired | +31,610 | $0.00 | $0 | 31,610 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Each RSU was granted on May 15, 2025 for no consideration.
Referenced by the price of 1 transaction in Table I.
- F4
This is the weighted average sales price representing 9,925 shares sold at prices ranging from $65.32 to $65.99 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.